1. Home
  2. JAGX vs TAOP Comparison

JAGX vs TAOP Comparison

Compare JAGX & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • TAOP
  • Stock Information
  • Founded
  • JAGX 2013
  • TAOP 1993
  • Country
  • JAGX United States
  • TAOP China
  • Employees
  • JAGX N/A
  • TAOP N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • TAOP Computer Software: Prepackaged Software
  • Sector
  • JAGX Health Care
  • TAOP Technology
  • Exchange
  • JAGX Nasdaq
  • TAOP Nasdaq
  • Market Cap
  • JAGX 3.1M
  • TAOP 3.6M
  • IPO Year
  • JAGX N/A
  • TAOP N/A
  • Fundamental
  • Price
  • JAGX $4.67
  • TAOP $0.25
  • Analyst Decision
  • JAGX
  • TAOP
  • Analyst Count
  • JAGX 0
  • TAOP 0
  • Target Price
  • JAGX N/A
  • TAOP N/A
  • AVG Volume (30 Days)
  • JAGX 39.3K
  • TAOP 169.4K
  • Earning Date
  • JAGX 03-31-2025
  • TAOP 05-05-2025
  • Dividend Yield
  • JAGX N/A
  • TAOP N/A
  • EPS Growth
  • JAGX N/A
  • TAOP N/A
  • EPS
  • JAGX N/A
  • TAOP 0.50
  • Revenue
  • JAGX $11,689,000.00
  • TAOP $42,636,173.00
  • Revenue This Year
  • JAGX $18.18
  • TAOP N/A
  • Revenue Next Year
  • JAGX $40.06
  • TAOP N/A
  • P/E Ratio
  • JAGX N/A
  • TAOP $0.40
  • Revenue Growth
  • JAGX 19.75
  • TAOP 37.49
  • 52 Week Low
  • JAGX $4.40
  • TAOP $0.23
  • 52 Week High
  • JAGX $540.00
  • TAOP $1.19
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.41
  • TAOP 35.78
  • Support Level
  • JAGX $4.41
  • TAOP $0.26
  • Resistance Level
  • JAGX $4.97
  • TAOP $0.27
  • Average True Range (ATR)
  • JAGX 0.88
  • TAOP 0.02
  • MACD
  • JAGX 0.09
  • TAOP -0.00
  • Stochastic Oscillator
  • JAGX 3.35
  • TAOP 16.43

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

Share on Social Networks: